Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT - Trial NCT06349824
Access comprehensive clinical trial information for NCT06349824 through Pure Global AI's free database. This Phase 4 trial is sponsored by Sheikh Zayed Medical College and is currently Completed. The study focuses on Carpal Tunnel Syndrome. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
NCT06349824
Phase 4
Completed
drug
Trial Details
ClinicalTrials.gov • NCT06349824
View on ClinicalTrials.gov
Dextrose, Steroid, PRP: Choosing the Right Injection for CRS Relief; a RCT
Dextrose, Steroid, PRP: Choosing the Right Injection for Long Term CRS Relief; a RCT
Study Focus
Sponsor & Location
Sheikh Zayed Medical College
Rahim yar khan, Pakistan
Timeline & Enrollment
Phase 4
Oct 10, 2023
Mar 30, 2024
60 participants
Primary Outcome
VAS
Summary
USG guided injections to relieve carpal tunnel syndrome with dextrose water or steroid or PRP
ICD-10 Classifications
Carpal tunnel syndrome
Tarsal tunnel syndrome
Arthrosis of first carpometacarpal joint, unspecified
Arthrosis of first carpometacarpal joint
Other specified disorders of synovium and tendon
Data Source
ClinicalTrials.gov
NCT06349824
Non-Device Trial